• School of Life & Health Sciences, Aston University, Aston Triangle

      B4 7ET Birmingham

      United Kingdom

    Accepting PhD Students

    Personal profile

    Research Interests

    Dr Kardeby is a cell signalling scientist with years of experience in drug target identification. Her research is in the field of Thrombosis in Inflammation with a focus on the effect of platelet and endothelial cell activation on vascular remodelling and neurodegeneration. In her work she uses novel pharmacological tools for understanding signalling mechanisms of cardiovascular disease.

    My research group currently consists of Dr Marcela Usmari Moraes, Miss Nusratul Firdaus, and one more PhD student joining us from October.

    Scholarship and Fellowship

    Dr Kardeby is a Marie Curie Alumni, she held a Marie Skłodowska-Curie Actions Individual Fellowship funded by Horizon 2020 between 2020 and 2022 (#893262).

    Clinical Experience

    Dr Kardeby is a registered clinical Biomedical Scientist with the Swedish National Board of Health and Welfare. She has experience from working in clinical chemistry, histolgy and pathology, fertility laboratory, and a general practician surgery.

    Research Projects/Collaborations

    The Connection Between Increased Thrombotic Risk and Parkinson’s – Currently recruiting

    The full title of this project is Investigating a novel mechanism underlying increased risk of vascular events in Parkinson’s disease:
    Dissecting pathological synergy between protein aggregates and glycosaminoglycans. It is funded by the British Heart Foundation and in collaboration with the University Hospitals Birmingham NHS Foundation Trust, this study aims to investigate whether individuals living with Parkinson’s have more easily activated platelets in their blood and to understand how alpha-synuclein and inflammation contributes to thrombosis. 

    PhD Project – Peripheral blood markers in South Asians with and without established coronary artery disease

    This project is a joint collaboration between the Sandwell and West Birmingham Hospitals NHS Trust and Aston University, funded 50-50 by the Listers Group and Aston University. In this project we aim to understand why individuals with South Asian ancestry are at increased risk of cardiovascular disease.

    PhD Project – Haemostatic dysregulation as a marker of blood brain barrier malfunction – Starting soon 

    This project is funded by the Dunhill Medical Trust, it is a part of the Aston Brain Health Cohort Study (ABaHCoS) that sits at the heart of the Aston Research Centre for Health in Ageing. This study will contribute towards finding new tools to identify individuals at risk of dementia earlier. The study is anticipated to start in October 2024 – more information coming soon.

    Education/Academic qualification

    PhD, Medicine, specialisation Biomedicine

    18 Nov 201429 May 2019

    Award Date: 2 Jul 2019

    MSc, Medicine, Örebro University


    BSc, Biomedical laboratory science, Uppsala University


    BSc, Medicine, Uppsala University



    • QP Physiology
    • Thrombosis
    • Platelets
    • Endothelial cells
    • Haemostasis
    • Inflammation
    • Glycosaminoglycans
    • Neurodegeneration
    • R Medicine (General)
    • Parkinson's disease
    • Aortic Aneurysms


    Dive into the research topics where Caroline Kardeby is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
    • 1 Similar Profiles

    Collaborations and top research areas from the last five years

    Recent external collaboration on country/territory level. Dive into details by clicking on the dots or